Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial
Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss of supporting bone. Limited data exist regarding the treatment of peri-implantitis. The aim of this study was to assess the clinical and micro...
Saved in:
Published in | Journal of periodontology (1970) Vol. 79; no. 5; p. 836 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2008
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss of supporting bone. Limited data exist regarding the treatment of peri-implantitis. The aim of this study was to assess the clinical and microbiologic outcome of repeated local administration of minocycline microspheres, 1 mg, in cases of peri-implantitis.
Thirty-two subjects with at least one implant with a probing depth > or =4 mm combined with bleeding and/or exudate on probing and the presence of putative pathogenic bacteria were included in the study. At baseline, subjects were randomly assigned to receive local minocycline microspheres (17 subjects and 57 implants) or chlorhexidine gel (15 subjects and 38 implants) following debridement. Treatments were performed on three occasions: baseline and days 30 and 90. Follow-up examinations were conducted at 10 days and at 1, 3, 6, 9, and 12 months.
The use of minocycline resulted in significant improvements in probing depths compared to chlorhexidine at days 30, 90, and 180 (P = 0.5, P = 0.01, and P = 0.04, respectively). For the deepest sites of the minocycline-treated implants, the mean probing depth reduction was 0.6 mm at 12 months. Regarding bleeding on probing, significant differences between groups, based on all four sites at the implants, were found at days 30, 90, 180, 270, and 360. Both treatments resulted in a marked reduction in the indicator bacteria.
The use of a repeated local antibiotic as an adjunct to the mechanical treatment of peri-implantitis lesions demonstrated improvements in probing depths that were significantly different from controls and were sustained for 6 months. The adjunctive use of minocycline microspheres is beneficial in the treatment of peri-implant lesions, but the treatment may have to be repeated. |
---|---|
AbstractList | Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss of supporting bone. Limited data exist regarding the treatment of peri-implantitis. The aim of this study was to assess the clinical and microbiologic outcome of repeated local administration of minocycline microspheres, 1 mg, in cases of peri-implantitis.
Thirty-two subjects with at least one implant with a probing depth > or =4 mm combined with bleeding and/or exudate on probing and the presence of putative pathogenic bacteria were included in the study. At baseline, subjects were randomly assigned to receive local minocycline microspheres (17 subjects and 57 implants) or chlorhexidine gel (15 subjects and 38 implants) following debridement. Treatments were performed on three occasions: baseline and days 30 and 90. Follow-up examinations were conducted at 10 days and at 1, 3, 6, 9, and 12 months.
The use of minocycline resulted in significant improvements in probing depths compared to chlorhexidine at days 30, 90, and 180 (P = 0.5, P = 0.01, and P = 0.04, respectively). For the deepest sites of the minocycline-treated implants, the mean probing depth reduction was 0.6 mm at 12 months. Regarding bleeding on probing, significant differences between groups, based on all four sites at the implants, were found at days 30, 90, 180, 270, and 360. Both treatments resulted in a marked reduction in the indicator bacteria.
The use of a repeated local antibiotic as an adjunct to the mechanical treatment of peri-implantitis lesions demonstrated improvements in probing depths that were significantly different from controls and were sustained for 6 months. The adjunctive use of minocycline microspheres is beneficial in the treatment of peri-implant lesions, but the treatment may have to be repeated. |
Author | Lindahl, Christel Renvert, Helena Dahlén, Gunnar Renvert, Stefan Lessem, Jan |
Author_xml | – sequence: 1 givenname: Stefan surname: Renvert fullname: Renvert, Stefan email: stefan.renvert@hv.hkr.se organization: Department of Health Sciences, Kristianstad University, Kristianstad, Sweden. stefan.renvert@hv.hkr.se – sequence: 2 givenname: Jan surname: Lessem fullname: Lessem, Jan – sequence: 3 givenname: Gunnar surname: Dahlén fullname: Dahlén, Gunnar – sequence: 4 givenname: Helena surname: Renvert fullname: Renvert, Helena – sequence: 5 givenname: Christel surname: Lindahl fullname: Lindahl, Christel |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18454662$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kMtOwzAQRb0oog9Ys0P-gZSJ4zg2O1TxkorYwLqyE7t1FSeW4yCFz-CLcVVYja5m5pzRLNGs6zuN0E0O61wAuTv2fk0A-BoqKGg1QwsAQrKCCjJHy2E4ppjTAi7RPOe0pIyRBfp50_VBdraWLZZdg4P2WkbdpBCts3XolU2teNBB-gmPg-32WOK2Py00YdzjRrf2S4cJD9MQtcO2O03jGBLH6S7i3mCvg82s8-2JGu1wnxAh6Xpnv5Orbu35ghiS7ApdGNkO-vqvrtDn0-PH5iXbvj-_bh62WV1WwLKiqJjgTBWGGs6l4KVhkpRM5MCB50YxIiWosmIN5FQRylVTFYIZZUolKCUrdHvm-lE53ex8sE6Gaff_HPIL3hxpJw |
CitedBy_id | crossref_primary_10_1111_j_1600_051X_2009_01443_x crossref_primary_10_1902_jop_2015_150464 crossref_primary_10_1002_cre2_286 crossref_primary_10_1111_cid_70010 crossref_primary_10_1016_j_jdent_2024_104980 crossref_primary_10_1007_s10103_014_1692_3 crossref_primary_10_1186_s40064_016_1735_2 crossref_primary_10_1155_2014_487903 crossref_primary_10_1563_aaid_joi_D_17_00261 crossref_primary_10_1097_ID_0000000000000846 crossref_primary_10_1002_bem_22481 crossref_primary_10_1111_j_1600_0501_2010_02124_x crossref_primary_10_3390_molecules26185661 crossref_primary_10_1111_prd_12049 crossref_primary_10_1089_photob_2023_0109 crossref_primary_10_1007_s40406_013_0007_5 crossref_primary_10_1902_jop_2015_150476 crossref_primary_10_1007_s12285_013_0416_1 crossref_primary_10_1111_jre_12681 crossref_primary_10_1111_jcpe_12006 crossref_primary_10_1111_clr_13456 crossref_primary_10_1155_2019_9374607 crossref_primary_10_1111_j_1600_0501_2010_02098_x crossref_primary_10_1111_j_1600_051X_2010_01561_x crossref_primary_10_1097_ID_0000000000000681 crossref_primary_10_1111_j_1600_051X_2011_01839_x crossref_primary_10_1097_ID_0000000000000832 crossref_primary_10_1007_s00784_015_1571_8 crossref_primary_10_3390_pharmaceutics16060769 crossref_primary_10_1002_jbm_b_31644 crossref_primary_10_1111_omi_12155 crossref_primary_10_1186_s40729_021_00388_x crossref_primary_10_1111_jcpe_13823 crossref_primary_10_1007_s12285_013_0386_3 crossref_primary_10_4103_jips_jips_64_24 crossref_primary_10_1902_jop_2011_100660 crossref_primary_10_1097_ID_0000000000000398 crossref_primary_10_1111_jcpe_12292 crossref_primary_10_1177_0022034518818479 crossref_primary_10_1111_prd_12069 crossref_primary_10_1007_s00784_015_1406_7 crossref_primary_10_1111_j_1600_051X_2012_01908_x crossref_primary_10_1038_sj_bdj_2014_858 crossref_primary_10_1016_j_jdent_2021_103790 crossref_primary_10_56373_2010_2_16 crossref_primary_10_1563_aaid_joi_D_22_00023 crossref_primary_10_1111_j_1600_051X_2011_01832_x crossref_primary_10_1111_j_1600_0501_2012_02494_x crossref_primary_10_1111_clr_13556 crossref_primary_10_4103_jdi_jdi_20_19 crossref_primary_10_1007_s00784_017_2310_0 crossref_primary_10_1111_jre_12707 crossref_primary_10_1016_j_jobcr_2020_03_012 crossref_primary_10_1111_idj_12034 crossref_primary_10_1016_j_oooo_2012_02_016 crossref_primary_10_3390_nano12244481 crossref_primary_10_3390_pharmaceutics12070668 crossref_primary_10_12968_denu_2015_42_2_166 crossref_primary_10_1563_aaid_joi_D_21_00204 crossref_primary_10_1016_j_jdent_2009_06_010 crossref_primary_10_3390_antibiotics11121766 crossref_primary_10_1111_clr_12733 crossref_primary_10_1002_14651858_CD003069_pub4 crossref_primary_10_3390_jfb15050114 crossref_primary_10_17827_aktd_1489140 crossref_primary_10_1002_JPER_20_0205 crossref_primary_10_3390_antibiotics9110835 crossref_primary_10_1111_prd_12122 crossref_primary_10_1016_j_prosdent_2024_03_024 crossref_primary_10_1111_j_1600_0501_2012_02542_x crossref_primary_10_1007_s00784_020_03240_5 crossref_primary_10_4028_www_scientific_net_JBBTE_11_21 crossref_primary_10_4012_dmj_2021_122 crossref_primary_10_34172_japid_2022_009 crossref_primary_10_1111_j_1600_051X_2010_01540_x crossref_primary_10_1111_clr_12686 crossref_primary_10_1111_j_2041_1626_2012_00116_x crossref_primary_10_1111_jcpe_13773 crossref_primary_10_17795_ajdr_21610 crossref_primary_10_3390_ma14226805 crossref_primary_10_1016_j_cden_2009_08_008 crossref_primary_10_1016_j_cden_2014_08_002 crossref_primary_10_3390_antibiotics13030269 crossref_primary_10_5005_jp_journals_10042_1019 crossref_primary_10_1016_j_cden_2019_02_003 crossref_primary_10_3390_app11114985 crossref_primary_10_1002_14651858_CD004970_pub5 crossref_primary_10_1111_cid_13006 crossref_primary_10_7759_cureus_48042 crossref_primary_10_1111_j_1600_051X_2009_01421_x crossref_primary_10_1111_clr_12155 crossref_primary_10_3390_antibiotics8020082 crossref_primary_10_1111_prd_12149 crossref_primary_10_3390_antibiotics10111298 crossref_primary_10_1111_j_1600_051X_2008_01276_x crossref_primary_10_1111_j_1600_051X_2012_01884_x crossref_primary_10_12968_denu_2019_46_10_986 crossref_primary_10_1007_s00284_010_9655_9 crossref_primary_10_1097_ID_0000000000000469 crossref_primary_10_1111_j_1600_051X_2011_01759_x crossref_primary_10_1002_JPER_20_0353 crossref_primary_10_1111_idh_12002 crossref_primary_10_51479_cspzl_2023_007 crossref_primary_10_1097_ID_0000000000000869 crossref_primary_10_1902_jop_2009_090152 crossref_primary_10_1089_pho_2009_2496 crossref_primary_10_1111_cid_12624 crossref_primary_10_1111_cid_12343 crossref_primary_10_1016_j_jdent_2010_03_003 crossref_primary_10_3390_app10155376 crossref_primary_10_3390_pharmaceutics3030538 crossref_primary_10_1111_clr_12147 crossref_primary_10_1007_s00784_014_1337_8 crossref_primary_10_1007_s00784_016_2033_7 crossref_primary_10_3390_ma16082953 crossref_primary_10_1097_ID_0b013e3182263589 crossref_primary_10_1111_ors_12548 crossref_primary_10_1111_prd_12159 crossref_primary_10_3233_BME_191074 crossref_primary_10_1111_j_1600_051X_2011_01762_x crossref_primary_10_1111_j_1600_0501_2009_01753_x crossref_primary_10_1186_s40729_015_0023_1 crossref_primary_10_15171_jlms_2016_24 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1902/jop.2008.070347 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Dentistry |
ExternalDocumentID | 18454662 |
Genre | Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -Y1 .55 0R~ 1OB 1OC 33P 34H 53G 5GY 5RE AAEUS AAHQN AAIPD AAMNL AANLZ AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCUV ABDQB ABJNI ABLJU ABOCM ABQWH ABXGK ACAHQ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADKYN ADMGS ADOZA ADXAS ADZMN AEIGN AENEX AEUYR AFFNX AFFPM AFGKR AFWVQ AGHNM AHBTC AIACR AITYG AIURR ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB BFHJK C45 CGR CS3 CUY CVF CWXXS DCZOG DRFUL DRMAN DRSTM DU5 EBS ECM EIF EJD F5P FUBAC GK1 HGLYW KBYEO L7B LATKE LEEKS LUTES LYRES MEWTI MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM NPM O9- OVD P2P P2W PER RJQFR ROL SAMSI SJN SUPJJ TEORI UCV UMD USG W99 WH7 WOHZO WXSBR X7M XZL YOJ ZE2 ZGI ZVN ZZTAW |
ID | FETCH-LOGICAL-c5706-3376986b3f4f88a985f6a2569108081fb62aa0b576d014b248bd7396fbf5b9442 |
ISSN | 0022-3492 |
IngestDate | Thu Apr 03 07:06:24 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5706-3376986b3f4f88a985f6a2569108081fb62aa0b576d014b248bd7396fbf5b9442 |
PMID | 18454662 |
ParticipantIDs | pubmed_primary_18454662 |
PublicationCentury | 2000 |
PublicationDate | May 2008 |
PublicationDateYYYYMMDD | 2008-05-01 |
PublicationDate_xml | – month: 05 year: 2008 text: May 2008 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of periodontology (1970) |
PublicationTitleAlternate | J Periodontol |
PublicationYear | 2008 |
SSID | ssj0021430 |
Score | 2.301655 |
Snippet | Peri-implantitis is an inflammatory process caused by microorganisms affecting the tissues around an osseointegrated implant in function, resulting in a loss... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 836 |
SubjectTerms | Adult Aged Anti-Infective Agents, Local - administration & dosage Bacteria - classification Bacteria - drug effects Chi-Square Distribution Chlorhexidine - administration & dosage Chlorhexidine - analogs & derivatives Colony Count, Microbial Combined Modality Therapy Delayed-Action Preparations Dental Implantation, Endosseous - adverse effects Dental Implants - adverse effects Dental Implants - microbiology Dental Scaling Female Follow-Up Studies Gels Humans Male Microspheres Middle Aged Minocycline - administration & dosage Periodontal Index Periodontitis - drug therapy Periodontitis - etiology Periodontitis - microbiology Prosthesis-Related Infections - drug therapy Prosthesis-Related Infections - microbiology Retreatment Single-Blind Method Statistics, Nonparametric |
Title | Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis: a randomized clinical trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18454662 |
Volume | 79 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZSOMAF8Yby0By4RQtJ1vba3BAFKqRygFbqrbJjGxYlm1UelejP4BczfuwjoUXAZRXZ0WR359M8nJlvCHmBCY4xGKpm-YSZjNqCZoJLkbGcWy3FmKkwvu3oEz88oR9P2elg0GcI3qz1y-nFpX0l_6NVXEO9-i7Zf9BsKxQX8DPqF6-oYbz-lY6PrO_bbfv9l7ZGy2o9-eq6nJeBYsnXkkfigOEmHAuoYXBfQ7PcfB0aO_N1GT8SoXNT9NhVn_t6aHySrJzXMxXoV1exPRpdnFnMywv8tba5MkwAuSLa9VIwA67WkfPJ00PJYtQ7h_hsq_PUP_RlbV2_VGi1srGXu1s8UN9m8T_-YDU_YBiulpeICl5VbR1tiK6QsN9qQOWWuY6zZxIsWc_2isik8ptPkIFj9vuiTpWzaOMiyWcPIfU8QATTXUZ5dA9_3t0h6W629sgepit-_qo_NEp5P4ako5a0Hp8mMUzhfb3auStPYZsk7aQ5Idw5vk1uJc3Bmwi6O2Rgq7vkxoGvLfPjAe-Rnx34ALEADfhgC3yQwAcBfKAggA88-KABH0TwQVn5b0MLPlg42AXfaxTRQQ8a6EGA3n1y8v7d8dvDLA34yKas8DWX6N2k4Dp31AmhpGCOK4zBpS98FWOn-USpkcaU2GAmrydUaFPkkjvtmJaUTh6Qa9Wiso8I0NwoJ4spp9qz2I2lNIpPi0Izasea68fkYXydZ3VkcTlrXvT-lTtPyM0OlU_JdYdmwz7DGHStnwcN_wKP3IiG |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanical+and+repeated+antimicrobial+therapy+using+a+local+drug+delivery+system+in+the+treatment+of+peri-implantitis%3A+a+randomized+clinical+trial&rft.jtitle=Journal+of+periodontology+%281970%29&rft.au=Renvert%2C+Stefan&rft.au=Lessem%2C+Jan&rft.au=Dahl%C3%A9n%2C+Gunnar&rft.au=Renvert%2C+Helena&rft.date=2008-05-01&rft.issn=0022-3492&rft.volume=79&rft.issue=5&rft.spage=836&rft_id=info:doi/10.1902%2Fjop.2008.070347&rft_id=info%3Apmid%2F18454662&rft_id=info%3Apmid%2F18454662&rft.externalDocID=18454662 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3492&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3492&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3492&client=summon |